BT-007
/ Bioceltech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 26, 2022
Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Bioceltech Therapeutics, Ltd.
CAR T-Cell Therapy • New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD7
1 to 1
Of
1
Go to page
1